Qumulo Announces Record Fiscal Year Results; Unveils Qumulo Core 5.0
Record-breaking results in software subscription billings, cloud billings, and customer adoption as the growth of…
Record-breaking results in software subscription billings, cloud billings, and customer adoption as the growth of…
Virtusa’s vGovern cloud governance solution powered by CoreStack’s NextGen FinOps, SecOps and CloudOps solutions BELLEVUE,…
Unique Rel-16 test capability speeds market introductions of advanced 5G NR features SANTA ROSA, Calif.–(BUSINESS…
NEW YORK & HOUSTON–(BUSINESS WIRE)–#proptech–Entera, the leading platform for single-family real estate investors, announced…
NEW YORK–(BUSINESS WIRE)–#brokerdealer–The OTC Markets (OTC) provides a trading platform for the trading of securities…
DANVERS, Mass.–(BUSINESS WIRE)–#BOD—CCC, a leader in advancing copyright, accelerating knowledge, and powering innovation, announces Justin…
Integration Enables Complete, Easy Indirect Tax Compliance and Enhanced Customer Experience AUSTIN, Texas–(BUSINESS WIRE)–Dooap, a…
New AI-based data extraction subscription service successfully launched 18% increase in staffing realigned as a…
SAN FRANCISCO–(BUSINESS WIRE)–Sigma Computing (“Sigma”), the cloud analytics and business intelligence (BI) innovator, today announced…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#cambridge—Cambridge Savings Bank (CSB), a full-service mutual bank with a customer-first approach and…
PLANO, Texas–(BUSINESS WIRE)–Diodes Incorporated (DIODES™) (Nasdaq: DIOD) has introduced a universal AC high-voltage input non-isolated…
Banyan Security, Keyfactor, ObserveID, Simeio and strongDM also join alliance to develop identity-centric security strategies…
BOCA RATON, Florida., Feb. 08, 2022 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”),…
WORCESTER, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
Joel Prieve brings nearly 20 years of commercial operations expertise and proven track record in…
INT301 Met Safety Goals Across Four Dose Levels in Cohort 1 Patient Treatment Now Ongoing…
Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results…
No additional clinical work required; NDA resubmission anticipated in Q3 2022 NEW YORK, Feb. 08,…
– Ovid to License Gaboxadol to Healx – – Healx to Explore Gaboxadol in Combination…